Computational Biotechnology | CMD Bioscience

TECHNOLOGY

PEPTIDE DISCOVERY

PARTNERING

CMDBioscience is committed to accelerating peptide discovery through the use of computation. By offering our groundbreaking computational discovery platform CMDInventus, CMDBioscience can equip partners with a best in class solution to their peptide discovery needs.

Our business model is to build collabortive research projects with partners that leverage CMDInventus and our expertise in computational chemistry and peptide design. You will get quality hits, greater molecular insight accelerated screening throughput and increased diversity space coverage.

Built from the ground up specifically for peptides, CMDInventus provides partner companies with unique access to all of the tasks expected of a computational biotech company with a unique and targeted focus on peptides

News and Events

CMDBiosience completes Series A financing round involving CT Innovations among other investors

Sept 26th, 2012 Joseph Audie, PhD CEO & CSO to present at Boulder Peptide Syposium, in the Peptide Showcase Session. This session highlights impactful start-up companies with potential to advance peptide therapeutics through the deployment of their technology along the peptide drug discovery value chain.

CMDBioscience and ChemModelling Inc. publication Release: Audie, J., Swanson, J. "Recent work in the Development of and Application of Protein- Protein Docking" Future Med Chem. 2012 Aug;4(12):1619-44.Releases

Accelerating Peptide Discovery

5 Science Park New Haven, CT 06511 203-298-4251 | info@cmdbioscience.com